Overview
A short-acting opioid anesthetic and analgesic derivative of fentanyl. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.
Background
A short-acting opioid anesthetic and analgesic derivative of fentanyl. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.
Indication
For the management of postoperative pain and the maintenance of general anesthesia.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/08/20 | Phase 4 | Not yet recruiting | |||
2024/05/14 | Not Applicable | Completed | |||
2024/01/19 | N/A | Completed | |||
2022/09/01 | N/A | Not yet recruiting | |||
2019/12/12 | Not Applicable | Completed | Nigde Omer Halisdemir University | ||
2019/01/23 | N/A | Completed | |||
2017/12/02 | Phase 4 | Completed | |||
2016/01/05 | Not Applicable | Completed | Pr Isabelle CONSTANT | ||
2015/12/09 | Not Applicable | Completed | |||
2015/07/01 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| RAPIFEN INJECTION 0.5 mg/ml | SIN04326P | INJECTION | 0.5 mg/ml | 5/3/1990 | |
| ALFENTANIL KALCEKS SOLUTION FOR INJECTION/ INFUSION 0.5MG/ML | SIN17055P | INJECTION, SOLUTION | 0.50mg/mL | 7/29/2024 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Alfentanil Hydrochloride Injection | 国药准字H20203055 | 化学药品 | 注射剂 | 2/25/2020 | |
| Alfentanil Hydrochloride Injection | 国药准字H20213854 | 化学药品 | 注射剂 | 11/9/2021 | |
| Alfentanil Hydrochloride Injection | 国药准字H20203054 | 化学药品 | 注射剂 | 2/25/2020 | |
| Alfentanil Hydrochloride Injection | 国药准字H20203056 | 化学药品 | 注射剂 | 2/25/2020 | |
| Alfentanil Hydrochloride Injection | 国药准字H20213853 | 化学药品 | 注射剂 | 11/9/2021 | |
| Alfentanil Hydrochloride Injection | 国药准字H20247083 | 化学药品 | 注射剂 | 4/23/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||